Boston Hospital Only New England Center Designated to Treat Ebola Patients
As part of a recent training session, staff members at the Center for Disaster Medicine in Boston trained on a ...
Tag: Select Agents
MSF Update on Ebola Frontline Response
Medical facilities, personnel and patients have continued to be the targets of violent attacks, with an increase in attacks and ...
Scientists Create Decoy Molecule that Neutralizes Arenaviruses
A host of disease-causing viruses called arenaviruses lurk in animal populations in various parts of the world, sometimes crossing over ...
Fresh Approach to an Old Problem Yields Clues to Tularemia Virulence
Francisella tularensis, also called rabbit fever, is an equal opportunity pathogen: it causes the disease tularemia in humans, rabbits and ...
Health Security Milestone: First FDA-Approved Ebola Vaccine
The U.S. Food and Drug Administration announced today the approval of ERVEBO®, the first FDA-approved vaccine for the prevention of ...
Ebola Patient Was Not Reinfected: Killed by Resurgence of Virus Lurking in Immune System
There was alarm last week among experts when the first reports came through that a patient had died after catching ...
Congo Authorities Say Ebola Survivor Falls Ill Second Time
An Ebola survivor has fallen ill with the disease for a second time in eastern Congo, the Congolese health authorities ...
British Nationals Evacuated from Sierra Leone for Lassa Fever Contact Monitoring
Three British nationals have been brought back to the UK from Sierra Leone for medical assessment after coming into close contact with ...
CDC Approves Partial Resumption of USAMRIID Select Agent Research
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) will resume limited research, following a successful recent inspection by ...
Hunter Contracts Bubonic Plague from Infected Rabbit, 28 People Quarantined
A hunter who killed and ate a wild rabbit on north China’s Mongolian steppe contracted bubonic plague, Chinese health officials ...
Phase 3 Trial of Modified Vaccinia Ankara as a Smallpox Vaccine
In today's New England Journal of Medicine, researchers describe the phase 3 trial results of the newly approved modified vaccinia Ankara ...
Tracing the Ancestral Genome of The Plague
An international team of researchers has analyzed remains from ten archaeological sites in England, France, Germany, Russia, and Switzerland to ...
Highly Diluted Dose of Ebola Vaccine Shown Effective in Primate Study
A single dose of VSV-Ebola virus vaccine—approximately one-millionth of what is in the vaccine being used in the outbreak outbreak ...
USAMRIID Study Leads to Approval of New Smallpox Vaccine
A new vaccine approved in the U.S. on Sept. 24 prevents both smallpox and the related disease monkeypox in adults. ...
Cutting Edge Chemical and Biological Defense Science: Hot Topics at CBD S&T 2019
In a few short weeks, the Defense Threat Reduction Agency (DTRA) will host the 2019 Chemical and Biological Defense Science ...
Why Do We Need a New Smallpox Vaccine?
The FDA approved the Jynneos Smallpox and Monkeypox Vaccine last week. The live, non-replicating vaccine is made from a vaccinia ...
BioFactura’s Smallpox Biodefense Therapeutic Awarded $67M BARDA Contract
BioFactura, Inc. today announced a contract awarded by the Biomedical Advanced Research and Development Authority (BARDA) valued at up to ...
FDA Approves Jynneos to Prevent Smallpox and Monkeypox
The U.S. Food and Drug Administration announced today the approval of Jynneos Smallpox and Monkeypox Vaccine, Live, Non-Replicating, for the ...
Biosafety Levels in Laboratories – What is the Difference?
In July 2019, the United States Army Medical Research Institute of Infectious Disease (USAMRIID) ceased research operations after failing to ...
DoD Inspector General to Reevaluate Select Agent Facilities, Biosafety Oversight
The Department of Defense Office of the Inspector General (DoD OIG) is conducting a Follow-Up Evaluation of DoD Biological Select ...
ADVERTISEMENT.
